• 1
    Gatta G, Capocaccia R, Coleman MP, et al. Toward a comparison of survival in American and European cancer patients. Cancer. 2000; 89: 893900.
  • 2
    Sant M, Capocaccia R, Verdecchia A, et al. Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. Int J Cancer. 1998; 77: 679683.
  • 3
    Quinn MJ, Martinez-Garcia C, Berrino F, EUROCARE Working Group. Variations in survival from breast cancer in Europe by age and country, 1978-1989. Eur J Cancer. 1998; 34: 22042211.
  • 4
    Sant M, EUROCARE Working Group. Differences in stage and therapy for breast cancer across Europe. Int J Cancer. 2001; 93: 894901.
  • 5
    Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985; 312: 16041608.
  • 6
    Sant M, Allemani C, Capocaccia R, et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer. 2003; 106: 416422.
  • 7
    SpiesslB, BeahrsOH, HermanekP, et al., editors. TNM atlas: illustrated guide to the TNM/pTNM classification of malignant tumors, 3rd ed. Berlin: Springer Verlag, 1992.
  • 8
    U.S. Department of Health and Human Services. National Cancer Institute, Surveillance, Epidemiology and End Results Program. SEER cancer statistics review, 1973-1999. [Dataset on CDROM]. Bethesda, MD: U.S. Department of Health and Human Services, 2001.
  • 9
    Ederer F, Axtell LM, Cutler SJ. The relative survival: a statistical methodology. Natl Cancer Inst Monogr. 1961; 6: 101121.
  • 10
    Estève J, Benhamou E, Croasdale M, et al. Relative survival and the estimation of net survival: elements for further discussion. Stat Med. 1990; 9: 529538.
  • 11
    Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Comput Programs Biomed. 1985; 19: 197207.
  • 12
    Dickman PW, Sloggett A, Hills M, et al. Regression models for relative survival analysis. Stat Med. 2004; 23: 5164.
  • 13
    Tabar L, Fagerberg CJ, Gad A, Baldetorp L, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985; i: 829832.
  • 14
    Tabar L, Fagerberg G, Duffy SW, et al. Update of the Swedish two-county program of mammographic screening for breast cancer. Radio Clin North Am. 1992; 30: 187210.
  • 15
    Hakama M, Pukkala E, Heikkilä KV, et al. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ. 1997; 314: 864867.
  • 16
    Blanks RG, Moss SM, McGahan CE, et al. Effect of NHS Breast Screening Programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ. 2000; 321: 665669.
  • 17
    Botha JL, Bray F, Sankila R, et al. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer. 2003; 39: 17181729.
  • 18
    Coleman MP, Gatta G, Verdecchia A, et al. Cancer survival in Europe at the end of the 20th century. Ann Oncol. In Press.
  • 19
    BerrinoF, CapocacciaR, EstèveJ, et al., editors. Survival of cancer patients in Europe: the EUROCARE-2 study. IARC Scientific Pub. No. 151. Lyon: International Agency for Research on Cancer, 1999.
  • 20
    BerrinoF, SantM, VerdecchiaA, CapocacciaR, HakulinenT, EstèveJ, editors. Survival of cancer patients in Europe: the EUROCARE study. IARC Scientific Pub. No. 132. Lyon: International Agency for Research on Cancer, 1995.
  • 21
    Berrino F, Gatta G, Sant M, et al. The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses. Eur J Cancer. 2001; 37: 673677.
  • 22
    Coleman MP, Babb P, Damiecki P, et al. Cancer survival trends in England and Wales 1971-1995: deprivation and NHS region. Series SMPS No. 61. London: The Stationery Office, 1999.
  • 23
    Coleman MP, Babb P, Quinn MJ, et al. Socio-economic inequalities in cancer survival in England and Wales. Cancer. 2001; 91: 208216.
  • 24
    Chevarley F, White E. Recent trends in breast cancer mortality among white and black US women. Am J Public Health. 1997; 87: 775781.
  • 25
    Mariotto A, Capocaccia R, Verdecchia A, et al. Projecting SEER cancer survival rates to the US: an ecological regression approach. Cancer Causes Control. 2002; 13: 101111.
  • 26
    Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment and survival by race and ethnicity. Arch Intern Med. 2003; 163: 4956.
  • 27
    Potosky AL, Merrill RM, Riley GF, et al. Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. J Natl Cancer Inst. 1997; 89: 16831691.
  • 28
    Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA. 1994; 271: 11631168.
  • 29
    Bradley CJ, Given CW, Roberts C. Race, socioeconomic status and breast cancer treatment and survival. J Natl Cancer Inst. 2002; 94: 490496.
  • 30
    McDavid K, Tucker T, Sloggett A, et al. Does cancer survival in Kentucky depend on health insurance coverage? Arch Intern Med. In Press.